Study indicates a very high level of resilience among Canadians with arthritis

A new study published by researchers at the University of Toronto indicates a very high level of resilience among Canadians with arthritis whose activities were restricted due to pain.

Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Show

Venetoclax (Venclexta) combined with a hypomethylating agent (HMA) — the standard of care for older patients with acute myeloid leukemia (AML) — appeared to be

May 10, 2024

Agios’ Pyrukynd succeeds in key trial of rare red blood cell disorder in kids

Agios’ blood disease treatment Pyrukynd passed a Phase 3 study in PK deficiency in children who do not regularly receive blood transfusions. The readout arrives

February 14, 2025

How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’

In the last two years, telehealth has gone all in on GLP-1s. Dozens of companies have started to offer the wildly popular obesity and diabetes

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.